Combined Serum (1,3)-β-D-Glucan and Oral Wash PCR as a Noninvasive Diagnostic Strategy for Early Detection of

Background: The diagnosis of Methods: This was a retrospective, single-center study including all immunosuppressed non-HIV adult patients with suspected PJP in whom a Fujifilm Wako β-glucan test BDG and BAL PJ in-house PCR determination were performed during a 5-year period (2019-2024). The diagnostic performance (negative predictive value [NPV], positive predictive value [PPV], and accuracy) of BDG alone, OW PJ PCR alone, and combined with OW PJ PCR, when available, was assessed in patients with PJP. PJP diagnosis was established according to EORTC/MSGERC 2021 criteria. Results: One hundred fourteen patients were included. PJP was confirmed in 15 patients (13.2%), of whom 14 had a positive BDG determination (median [interquartile range], 55.32 [19.98-137.90] pg/mL). BDG PPV was low (51.7%), but the overall accuracy (87.7%) for PJP diagnosis was good. Forty-seven (41%) patients had an OW performed, 11 of whom were diagnosed with PJP. The combined use of BDG and OW PJ PCR showed a high PPV (100%) and NPV (97.3%) and an excellent diagnostic accuracy (97.9%) for PJP diagnosis in this patient subset. Conclusions: The additional use of OW PJ PCR to BDG should be considered as an accurate, noninvasive combined diagnostic strategy for PJP diagnosis.